Xeris Pharmaceuticals Inc.

This stock has a reasonable momentum. Xeris Pharmaceuticals Inc. is not a good value stock. Xeris Pharmaceuticals Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Xeris Pharmaceuticals Inc..

Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-u...

News

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Could Be Riskier Than It Looks

Simply Wall St With a price-to-sales (or "P/S") ratio of 2.1x Xeris Biopharma Holdings, Inc. ( NASDAQ:XERS ) may be sending bullish...\n more…

Xeris to Participate in Upcoming Investor Conferences

Business Wire Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients lives by developing and commercializing innovative products across a range...\n more…

Xeris Biopharma Holdings Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St Xeris Biopharma Holdings ( NASDAQ:XERS ) Second Quarter 2024 Results Key Financial Results Revenue: US$48.1m (up 27...\n more…

Xeris Biopharma Holdings Loses US$52m Market Value But Insiders See Windfall Of US$29k

Simply Wall St Insiders who bought Xeris Biopharma Holdings, Inc. ( NASDAQ:XERS ) in the last 12 months may probably not pay attention...\n more…

XERS Stock Earnings: Xeris Biopharma Holdings Beats EPS, Beats Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nXERS stock results show that Xeris Biopharma Holdings beat analyst estimates for earnings per share and beat on revenue for the second...\n more…

Xeris Biopharma Holdings, Inc. (XERS) Q2 2024 Earnings Call Transcript

SeekingAlpha Xeris Biopharma Holdings, Inc. (XERS) Q2 2024 Earnings Call Transcript...\n more…